Neonatal opioid withdrawal syndrome: a review of the science and a look toward the use of buprenorphine for affected infants

Affiliations

• ¹ Department of Pediatrics, Division of Neonatal Medicine, University of Louisville School of Medicine, Louisville, KY, USA. lori.devlinphinney@louisville.edu.
• ² Department of Pediatrics, The Robert Larner, MD, College of Medicine, University of Vermont, Burlington, VT, USA.
• ³ Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, USA.
• ⁴ Department of Pediatrics, Boston University School of Medicine, Boston, MA, USA.
• ⁵ Department of Pediatrics, Warren Alpert Medical School, Brown University, Providence, RI, USA.
• ⁶ Perinatal Institute, Division of Neonatology, Cincinnati Children's Hospital and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
• ⁷ Department of Psychiatry and Behavioral Neuroscience, Center for Addiction Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
• ⁸ Department of Obstetrics and Gynecology, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
• ⁹ Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia.
• ¹⁰ Department of Medical Social Sciences, Feinberg School of Medicine & Institute for Innovations in Developmental Sciences, Northwestern University, Evanston, IL, USA.
• ¹¹ Virginia Commonwealth University School of Nursing, Richmond, VA, USA.
• ¹² The Emmes Company, Rockville, MD, USA.
• ¹³ Department of Pediatrics and the Tufts Clinical and Translational Science Institute, Tufts University School of Medicine, Boston, MA, USA.